Selected research
Industry Research
Neohesperidoside Industry Research Report 2026
Market perspective
The global Neohesperidoside market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neohesperidoside is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neohesperidoside is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Neohesperidoside is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neohesperidoside include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neohesperidoside market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Neohesperidoside.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neohesperidoside Market by Company
Biospringer
DowDuPont
BASF SE
FMC Health and Nutrition
Firmenich SA
Edlong Dairy Technologies
CP Kelco
Corbion NV
Chr.Hansen Holding A/S
Cargill
Neohesperidoside Segment by Type
Pharmacy Grade
Food Grade
Industrial Grade
Neohesperidoside Segment by Application
Cosmetics
Food
Medicine
Neohesperidoside Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neohesperidoside market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neohesperidoside and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neohesperidoside.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neohesperidoside manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neohesperidoside by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neohesperidoside in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmacy Grade
- Food Grade
- Industrial Grade
Applications
- Cosmetics
- Food
- Medicine
Companies covered
- Biospringer
- DowDuPont
- BASF SE
- FMC Health and Nutrition
- Firmenich SA
- Edlong Dairy Technologies
- CP Kelco
- Corbion NV
- Chr.Hansen Holding A/S
- Cargill
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neohesperidoside by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Pharmacy Grade
- 2.2.3 Food Grade
- 2.2.4 Industrial Grade
- 2.3 Neohesperidoside by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cosmetics
- 2.3.3 Food
- 2.3.4 Medicine
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Neohesperidoside Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Neohesperidoside Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Neohesperidoside Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neohesperidoside Production by Manufacturers (2021-2026)
- 3.2 Global Neohesperidoside Production Value by Manufacturers (2021-2026)
- 3.3 Global Neohesperidoside Average Price by Manufacturers (2021-2026)
- 3.4 Global Neohesperidoside Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Neohesperidoside Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Neohesperidoside Manufacturers, Product Type & Application
- 3.7 Global Neohesperidoside Manufacturers Established Date
- 3.8 Global Neohesperidoside Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Biospringer
- 4.1.1 Biospringer Neohesperidoside Company Information
- 4.1.2 Biospringer Neohesperidoside Business Overview
- 4.1.3 Biospringer Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Biospringer Product Portfolio
- 4.1.5 Biospringer Recent Developments
- 4.2 DowDuPont
- 4.2.1 DowDuPont Neohesperidoside Company Information
- 4.2.2 DowDuPont Neohesperidoside Business Overview
- 4.2.3 DowDuPont Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 DowDuPont Product Portfolio
- 4.2.5 DowDuPont Recent Developments
- 4.3 BASF SE
- 4.3.1 BASF SE Neohesperidoside Company Information
- 4.3.2 BASF SE Neohesperidoside Business Overview
- 4.3.3 BASF SE Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 BASF SE Product Portfolio
- 4.3.5 BASF SE Recent Developments
- 4.4 FMC Health and Nutrition
- 4.4.1 FMC Health and Nutrition Neohesperidoside Company Information
- 4.4.2 FMC Health and Nutrition Neohesperidoside Business Overview
- 4.4.3 FMC Health and Nutrition Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 FMC Health and Nutrition Product Portfolio
- 4.4.5 FMC Health and Nutrition Recent Developments
- 4.5 Firmenich SA
- 4.5.1 Firmenich SA Neohesperidoside Company Information
- 4.5.2 Firmenich SA Neohesperidoside Business Overview
- 4.5.3 Firmenich SA Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Firmenich SA Product Portfolio
- 4.5.5 Firmenich SA Recent Developments
- 4.6 Edlong Dairy Technologies
- 4.6.1 Edlong Dairy Technologies Neohesperidoside Company Information
- 4.6.2 Edlong Dairy Technologies Neohesperidoside Business Overview
- 4.6.3 Edlong Dairy Technologies Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Edlong Dairy Technologies Product Portfolio
- 4.6.5 Edlong Dairy Technologies Recent Developments
- 4.7 CP Kelco
- 4.7.1 CP Kelco Neohesperidoside Company Information
- 4.7.2 CP Kelco Neohesperidoside Business Overview
- 4.7.3 CP Kelco Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 CP Kelco Product Portfolio
- 4.7.5 CP Kelco Recent Developments
- 4.8 Corbion NV
- 4.8.1 Corbion NV Neohesperidoside Company Information
- 4.8.2 Corbion NV Neohesperidoside Business Overview
- 4.8.3 Corbion NV Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Corbion NV Product Portfolio
- 4.8.5 Corbion NV Recent Developments
- 4.9 Chr.Hansen Holding A/S
- 4.9.1 Chr.Hansen Holding A/S Neohesperidoside Company Information
- 4.9.2 Chr.Hansen Holding A/S Neohesperidoside Business Overview
- 4.9.3 Chr.Hansen Holding A/S Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Chr.Hansen Holding A/S Product Portfolio
- 4.9.5 Chr.Hansen Holding A/S Recent Developments
- 4.10 Cargill
- 4.10.1 Cargill Neohesperidoside Company Information
- 4.10.2 Cargill Neohesperidoside Business Overview
- 4.10.3 Cargill Neohesperidoside Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Cargill Product Portfolio
- 4.10.5 Cargill Recent Developments
5 Global Neohesperidoside Production by Region
- 5.1 Global Neohesperidoside Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neohesperidoside Production by Region: 2021-2032
- 5.2.1 Global Neohesperidoside Production by Region: 2021-2026
- 5.2.2 Global Neohesperidoside Production Forecast by Region (2027-2032)
- 5.3 Global Neohesperidoside Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Neohesperidoside Production Value by Region: 2021-2032
- 5.4.1 Global Neohesperidoside Production Value by Region: 2021-2026
- 5.4.2 Global Neohesperidoside Production Value Forecast by Region (2027-2032)
- 5.5 Global Neohesperidoside Market Price Analysis by Region (2021-2026)
- 5.6 Global Neohesperidoside Production and Value, YOY Growth
- 5.6.1 North America Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Neohesperidoside Production Value Estimates and Forecasts (2021-2032)
6 Global Neohesperidoside Consumption by Region
- 6.1 Global Neohesperidoside Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Neohesperidoside Consumption by Region (2021-2032)
- 6.2.1 Global Neohesperidoside Consumption by Region: 2021-2026
- 6.2.2 Global Neohesperidoside Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Neohesperidoside Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Neohesperidoside Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Neohesperidoside Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Neohesperidoside Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Neohesperidoside Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Neohesperidoside Production by Type (2021-2032)
- 7.1.1 Global Neohesperidoside Production by Type (2021-2032) & (t)
- 7.1.2 Global Neohesperidoside Production Market Share by Type (2021-2032)
- 7.2 Global Neohesperidoside Production Value by Type (2021-2032)
- 7.2.1 Global Neohesperidoside Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Neohesperidoside Production Value Market Share by Type (2021-2032)
- 7.3 Global Neohesperidoside Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Neohesperidoside Production by Application (2021-2032)
- 8.1.1 Global Neohesperidoside Production by Application (2021-2032) & (t)
- 8.1.2 Global Neohesperidoside Production Market Share by Application (2021-2032)
- 8.2 Global Neohesperidoside Production Value by Application (2021-2032)
- 8.2.1 Global Neohesperidoside Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Neohesperidoside Production Value Market Share by Application (2021-2032)
- 8.3 Global Neohesperidoside Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Neohesperidoside Value Chain Analysis
- 9.1.1 Neohesperidoside Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Neohesperidoside Production Mode & Process
- 9.2 Neohesperidoside Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Neohesperidoside Distributors
- 9.2.3 Neohesperidoside Customers
10 Global Neohesperidoside Analyzing Market Dynamics
- 10.1 Neohesperidoside Industry Trends
- 10.2 Neohesperidoside Industry Drivers
- 10.3 Neohesperidoside Industry Opportunities and Challenges
- 10.4 Neohesperidoside Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst